Breast-specific antigens, such as mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15), are now widely utilized to aid in the diagnosis of metastatic tumors from breast carcinoma. This evidence concerns the gene PIP and metastatic neoplasm.